Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis

Br J Rheumatol. 1998 May;37(5):590-2. doi: 10.1093/rheumatology/37.5.590.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antiemetics / therapeutic use*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / pathology
  • Female
  • Humans
  • Male
  • Methotrexate / adverse effects*
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Ondansetron / therapeutic use*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antiemetics
  • Antirheumatic Agents
  • Ondansetron
  • Methotrexate